Publications by authors named "Alan Blayney"

Claim this Profile
I
Intrinsically Disordered N-terminal Domain (NTD) of p53 Interacts with Mitochondrial PTP Regulator Cyclophilin D.
Jing Zhao, Xinyue Liu, Alan Blayney, Yumeng Zhang, Lauren Gandy

J Mol Biol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benzothiazolyl and Benzoxazolyl Hydrazones Function as Zinc Metallochaperones to Reactivate Mutant p53.
John A Gilleran, Xin Yu, Alan J Blayney, Anthony F Bencivenga, Bing Na

J Med Chem· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EGCG binds intrinsically disordered N-terminal domain of p53 and disrupts p53-MDM2 interaction.
Jing Zhao, Alan Blayney, Xiaorong Liu, Lauren Gandy, Weihua Jin

Nat Commun· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zinc shapes the folding landscape of p53 and establishes a pathway for reactivating structurally diverse cancer mutants.
Adam R Blanden, Xin Yu, Alan J Blayney, Christopher Demas, Jeung-Hoi Ha

Elife· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combinatorial Therapy of Zinc Metallochaperones with Mutant p53 Reactivation and Diminished Copper Binding.
Saif Zaman, Xin Yu, Anthony F Bencivenga, Adam R Blanden, Yue Liu, Alan J Blayney

Mol Cancer Ther· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis